XML 22 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating Activities    
Net Income $ 408 $ 351
Net Income 401 361
Adjustments to reconcile Net Income to Net cash from operating activities:    
Depreciation and amortization 296 281
Nuclear fuel amortization 15 15
Allowance for equity funds used during construction (7) (7)
Deferred income taxes 49 60
Equity earnings of equity method investees (23) (21)
Dividends from equity method investees 44 15
Changes in assets and liabilities:    
Accounts receivable, net 143 33
Inventories 207 182
Prepaid postretirement benefit costs (31) 0
Accounts payable (288) (136)
Gas inventory equalization 88 85
Accrued pension liability (115) (187)
Accrued postretirement liability 0 (36)
Derivative assets and liabilities (15) (7)
Regulatory assets and liabilities 112 148
Other current and noncurrent assets and liabilities (131) 62
Net cash from operating activities 752 838
Investing Activities    
Plant and equipment expenditures — utility (641) (466)
Plant and equipment expenditures — non-utility (27) (61)
Notes receivable (48)  
Proceeds from sale of nuclear decommissioning trust fund assets 176 336
Investment in nuclear decommissioning trust funds (178) (337)
Distributions from equity method investees 1 4
Contributions to equity method investees (22) (64)
Notes receivable   3
Other (9) (1)
Net cash used for investing activities (748) (586)
Financing Activities    
Issuance of long-term debt, net of issuance costs 644 0
Short-term borrowings, net (453)  
Short-term borrowings, net   14
Dividends paid on common stock (172) (158)
Contributions from noncontrolling interest, principally REF entities 9 12
Distributions to noncontrolling interests (21) (4)
Other (26) (19)
Net cash from (used for) financing activities (19) (155)
Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash (15) 97
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 76 89
Cash, Cash Equivalents, and Restricted Cash at End of Period 61 186
Supplemental disclosure of non-cash investing and financing activities    
Plant and equipment expenditures in accounts payable 235 179
DTE Electric    
Operating Activities    
Net Income 147 140
Adjustments to reconcile Net Income to Net cash from operating activities:    
Depreciation and amortization 221 212
Nuclear fuel amortization 15 15
Allowance for equity funds used during construction (6) (5)
Deferred income taxes 23 48
Changes in assets and liabilities:    
Accounts receivable, net 47 39
Inventories 51 50
Accounts payable (36) (30)
Accrued pension liability — affiliates (103) (178)
Accrued postretirement liability — affiliates (21) (24)
Regulatory assets and liabilities 130 97
Other current and noncurrent assets and liabilities (146) (41)
Net cash from operating activities 322 323
Investing Activities    
Plant and equipment expenditures (531) (370)
Notes receivable (96) 0
Proceeds from sale of nuclear decommissioning trust fund assets 176 336
Investment in nuclear decommissioning trust funds (178) (337)
Other (10) 0
Net cash used for investing activities (639) (371)
Financing Activities    
Issuance of long-term debt, net of issuance costs 644 0
Short-term borrowings, net — affiliate (50) 26
Short-term borrowings, net — other (149) 142
Dividends paid on common stock (124) (115)
Other (12) (4)
Net cash from (used for) financing activities 309 49
Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash (8) 1
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 18 15
Cash, Cash Equivalents, and Restricted Cash at End of Period 10 16
Supplemental disclosure of non-cash investing and financing activities    
Plant and equipment expenditures in accounts payable $ 140 $ 109